WiDH presents: Digital Health and Sustainability
October 6 @ 6:30 pm - 8:00 pm
Join us at our live event and learn all about how digital health can contribute to sustainable development, and the role healthcare companies, healthcare professionals and patients can play in pursuing ESG goals to shape the future of health.
What to expect
What does the future of digital health look like, and how can we drive healthcare innovation that is not only more human-centric but also more sustainable – financially, socially, and environmentally? How can companies, healthcare providers, digital health startups, patients and governments collaborate to achieve sustainable development goals together?
Join us in an interactive discussion on the latest developments in digital health and sustainability this October with healthcare innovator Cécile Tardy-Srinivasan from DayOne, a leading healthcare innovation initiative run by Basel Area Business and Innovation, and Carol Anne Krech, Chief Operating Officer, MiSANTO AG, a leading telemedicine company that is at the forefront of tackling the COVID pandemic in Switzerland.
About Carols presentation: Digitising health needs a shift in the health care system – not only for patients, but also for professionals, politics and the public. Digitalised medicine seems to be our only chance and thus unavoidable if we want to ensure adequate primary care. Her speech explains the “pains” of the current un-digitised medicine and the “gains” of the future digitised medicine by showing how we can reduce hurdles and increase personal, environmental and economical sustainability
18: 30 Door opening and registration
18:45 Programme start, welcome by Women in Digital Health
18:50 Presentation by Cécile Tardy-Srinivasan, DayOne Accelerator manager, Health 4.0
19:10 Presentation by Carol Krech, Chief Operating Officer, MiSANTO AG
19:30 Moderated discussion, followed by a Q&A from the audience
20:00 Networking Apéro
About the speakers
Cécile Tardy-Srinivasan has been working for Basel Area Business & Innovation since 2021.
Previously, she worked at big pharma companies like Novartis, where she held various roles at country, regional and global levels. She brings a background in finance from working with EY. As a healthcare innovation consultant, she has been focusing on patient centricity and co-creating solutions among stakeholders of the healthcare ecosystem. Through the DayOne acceleration program, she supports digital health startups to scale up at the interface with the Pharma industry.
Cécile Tardy-Srinivasan studied Design Thinking at the MIT Sloan School of Management and holds a Master’s in Management from the EDHEC Business School, France.
Carol-Anne Krech is the COO of MiSANTO and holds an Master of Arts from Sankt Gallen University (HSG) in Business Innovation, Technology and Entrepreneurship. Her international studies include a semester at Singapore Management University for her B.A. in Economics, Organization and Leadership. She wrote her Master’s thesis on „Intellectual Property under Crowdfunding” and started her PhD in Innovation Management. Her publication “Profiting from Invention: Business Models of Patent Aggregators“ was recognized with the “Best Paper Award” of the International Society for Business Innovation Management.
Prior joining MiSANTO she developed selftesting.ch and worked as a Project Director for Bühler Group AG, managing cross Business Area Projects, was well as aligning business processes and strategy at their biggest Chinese production site.